ClinicalTrials.gov
public full text
Public Domain
Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)
AEE788 is an orally active, reversible, small-molecule, multi-targeted kinase inhibitor with potent inhibitory activity against the ErbB and VEGF receptor family of tyrosine kinases. It has an IC50 of less than 100 nM against p-EGFR, p-ErbB2, and p-KDR (VEGFR2). This study will assess the safety, pharmacokinetic/pharmacodynamic (PK/PD) profiles and clinical activity of AEE788 in a recurrent GBM population.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma#1139304
- A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme#1171612
- Trial of Dichloroacetate (DCA) in Glioblastoma Multiforme (GBM)#1138592
- Combination Therapy for the Treatment of Diffuse Midline Gliomas#1127068
- INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas#913417
Record · ID 969886
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive